EW vs OPY
Edwards Lifesciences Corp (EW) versus Oppenheimer Holdings Inc (OPY) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Oppenheimer Holdings Inc (OPY) is a capital markets company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported OPY revenue for 2024-12-31 was $1.43B. Net income was $71.2M. Revenue was up 14.7% from 2023-12-31 to 2024-12-31. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
EW currently screens at market cap $49.91B and trailing P/E 46.9. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
Not investment advice. Open the EW and OPY stock pages for the full models.
Not investment advice.